Ovid Therapeutics Inc (NASDAQ:OVID)
| 2.86 Delayed Data As of Mar 28 |  +0.06 / +2.14%Today’s Change | 1.41 Today|||52-Week Range 3.40 | +53.76% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 27.9K | 31.4K | 55.3K | 76.5K | ||
| Operating Expenses | Gross Income | -27.9K | -31.4K | -55.3K | -76.5K | |
| General Expenses | 13.2M | 13.1M | 13.1M | 14.0M | ||
| Research And Development | 8.1M | 8.5M | 8.6M | 9.3M | ||
| Total Operating Expenses | 13.2M | 13.2M | 13.1M | 14.1M | ||
| Non-Operating Expenses | Operating Income | -13.2M | -13.2M | -13.1M | -14.1M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.9M | -13.0M | -12.9M | -13.8M | |
| Net Income | -12.9M | -13.0M | -12.9M | -13.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 24.6M | 24.6M | 24.6M | 30.3M | |
| Shares To Calculate EPS Diluted | 24.6M | 24.6M | 24.6M | 30.3M | ||
| Earnings Per Share | EPS | -$0.53 | -$0.53 | -$0.52 | -$0.46 | |
| EPS Diluted | -$0.53 | -$0.53 | -$0.52 | -$0.46 | ||
